Lise Jamieson
Lise Jamieson
Senior Researcher, Health Economics and Epidemiology Research Office, University of Witwatersrand
Verified email at
Cited by
Cited by
The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection
ES Gray, MC Madiga, T Hermanus, PL Moore, CK Wibmer, NL Tumba, ...
Journal of virology 85 (10), 4828-4840, 2011
Genital inflammation and the risk of HIV acquisition in women
L Masson, JAS Passmore, LJ Liebenberg, L Werner, C Baxter, KB Arnold, ...
Clinical Infectious Diseases 61 (2), 260-269, 2015
High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers
MR O'Donnell, J Jarand, M Loveday, N Padayatchi, J Zelnick, L Werner, ...
Annals of internal medicine 153 (8), 516-522, 2010
Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women
SSA Karim, ADM Kashuba, L Werner, QA Karim
The Lancet 378 (9787), 279-281, 2011
Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa
K Mlisana, N Naicker, L Werner, L Roberts, F Van Loggerenberg, ...
The Journal of infectious diseases 206 (1), 6-14, 2012
Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study
L Masson, K Mlisana, F Little, L Werner, NN Mkhize, K Ronacher, ...
Sexually transmitted infections 90 (8), 580-587, 2014
Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa
QA Karim, ABM Kharsany, JA Frohlich, L Werner, M Mashego, ...
International journal of epidemiology 40 (4), 922-930, 2011
Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection
MR O’Donnell, N Padayatchi, C Kvasnovsky, L Werner, I Master, ...
Emerging infectious diseases 19 (3), 416, 2013
Tenofovir gel for the prevention of herpes simplex virus type 2 infection
SS Abdool Karim, Q Abdool Karim, ABM Kharsany, C Baxter, AC Grobler, ...
New England Journal of Medicine 373 (6), 530-539, 2015
Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis
DD Naicker, L Werner, E Kormuth, JA Passmore, K Mlisana, SA Karim, ...
Journal of Infectious Diseases 200 (3), 448-452, 2009
Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection
R Singh, G Gaiha, L Werner, K McKim, K Mlisana, J Luban, BD Walker, ...
Journal of virology 85 (1), 208-216, 2011
Duffy-null–associated low neutrophil counts influence HIV-1 susceptibility in high-risk south african black women
V Ramsuran, H Kulkarni, W He, K Mlisana, EJ Wright, L Werner, ...
Clinical Infectious Diseases 52 (10), 1248-1256, 2011
Genital tenofovir concentrations correlate with protection against HIV infection in the CAPRISA 004 trial: importance of adherence for microbicide effectiveness
ADM Kashuba, TN Gengiah, L Werner, KH Yang, NR White, QA Karim, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 69 (3), 264-269, 2015
APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load
K Reddy, CA Winkler, L Werner, K Mlisana, SSA Karim, T Ndung'u, ...
Aids 24 (2), 195-204, 2010
Rifampicin Mono-Resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: A Significant Phenomenon in a High Prevalence TB-HIV Region
YM Coovadia, S Mahomed, M Pillay, L Werner, K Mlisana
PloS one 8 (11), e77712, 2013
HIV incidence in young girls in KwaZulu-Natal, South Africa-public health imperative for their inclusion in HIV biomedical intervention trials
Q Abdool Karim, ABM Kharsany, JA Frohlich, L Werner, M Mlotshwa, ...
AIDS and Behavior 16, 1870-1876, 2012
Prevalence, incidence, predictors, treatment, and control of hypertension among HIV-positive adults on antiretroviral treatment in public sector treatment programs in South Africa
AT Brennan, L Jamieson, NJ Crowther, MP Fox, JA George, KM Berry, ...
PloS one 13 (10), e0204020, 2018
Human TRIM5α expression levels and reduced susceptibility to HIV-1 infection
S Sewram, R Singh, E Kormuth, L Werner, K Mlisana, SSA Karim, ...
The Journal of infectious diseases 199 (11), 1657-1663, 2009
Changes in Natural Killer cell activation and function during primary HIV-1 Infection
V Naranbhai, M Altfeld, SSA Karim, T Ndung'u, QA Karim, WH Carr
PloS one 8 (1), e53251, 2013
HIV prevention in high-risk women in South Africa: condom use and the need for change
F van Loggerenberg, AA Dieter, ME Sobieszczyk, L Werner, A Grobler, ...
PloS one 7 (2), e30669, 2012
The system can't perform the operation now. Try again later.
Articles 1–20